Comprehensive Guide to Gefitinib 250mg (GEFISTERIS 250): Uses, Dosage, and Side Effects

Jul 17, 2024

GEFISTERIS 250

Gefitinib (250mg)

Introduction

Gefitinib 250mg, marketed under the name GEFISTERIS 250, is a potent medication primarily used to treat non-small cell lung cancer (NSCLC). It functions as a tyrosine kinase inhibitor, targeting the epidermal growth factor receptor (EGFR) to inhibit cancer cell growth. This article delves into the uses, dosage, side effects, and pricing of GEFISTERIS 250 in India.

Uses

GEFISTERIS 250 is specifically prescribed for patients with non-small cell lung cancer that is positive for EGFR mutations. By blocking the activity of EGFR, gefitinib helps to slow down or stop the proliferation of cancer cells. This targeted therapy is often chosen for its precision in attacking cancer cells while minimizing damage to normal cells, making it a preferred treatment option for certain NSCLC patients.

Dosage

The recommended dosage of GEFISTERIS 250 for adult patients is one 250mg tablet taken once daily. It is crucial to take the medication at the same time each day to maintain consistent drug levels in the body. The tablet can be taken with or without food, but it should be swallowed whole with a glass of water. If a dose is missed, it should be taken as soon as possible unless it is almost time for the next dose. In such cases, the missed dose should be skipped, and the regular dosing schedule should be resumed. It is important not to double the dose to make up for the missed one.

Side Effects

While GEFISTERIS 250 is effective in treating NSCLC, it can also cause various side effects. Common side effects include diarrhea, skin reactions (such as rash or acne), nausea, vomiting, and loss of appetite. Some patients may experience more severe side effects such as liver toxicity, interstitial lung disease, or severe gastrointestinal issues. Patients need to report any side effects to their healthcare provider promptly to manage them effectively and adjust the treatment if necessary.

Price

The price of GEFISTERIS 250 in India varies depending on the manufacturer and the pharmacy. On average, a month's supply of GEFISTERIS 250 (30 tablets) costs around INR 25,000 to INR 35,000. It is advisable to check with local pharmacies and consider generic versions for more cost-effective options.

Conclusion

GEFISTERIS 250, or Gefitinib 250mg, is a vital medication in the treatment of non-small cell lung cancer with EGFR mutations. Its targeted action on cancer cells, along with a manageable side effect profile, makes it a key player in cancer therapy. Patients should follow their prescribed dosage and consult their healthcare providers regularly to monitor their response to the treatment and manage any adverse effects. With the right guidance and support, GEFISTERIS 250 can significantly improve the quality of life for those battling NSCLC. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma  Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information:

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

Buy Now:

SHARE WITH